MAP/microtubule Affinity-Regulating Kinase 4 (MARK4) Antikörper

Antigen: MAP/microtubule Affinity-Regulating Kinase 4 (MARK4)

Synonyme: MARKL1, FLJ90097, KIAA1860, Nbla00650, C79806, Markl1, 2410090P21Rik, MARK4

Klonalität: Polyklonal

Wirt: Ziege

Reaktivität: Human

Applikation: ELISA, Western Blot (WB)

Produktnummer: ABIN184722

Produktbeschreibung

Weitere Bezeichnung: MARK4

Gen-ID: 57787

Immunogen: IKRKPPPGCSDSPGV

Format: Affinity-purified

Beschreibung: All names and symbols: MARK4, MAP/microtubule affinity-regulating kinase 4, MARKL1, KIAA1860, Nbla00650, MARK4 serine/threonine protein kinase, MAP/microtubule affinity-regulating kinase like 1. Official Symbol: MARK4. RefSeq number(s): NP_113605.2

Spezifität: Human

Anwendungen

Applikationshinweise: Peptide ELISA: antibody detection limit dilution 1:128,000. Western Blot: Approx 70kDa band observed in human prostate lysates (calculated MW of 75.3kDa according to NP_113605.2). Recommended concentration: 0.3-1µg/ml.

Reinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Buffer: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.

Lagerung: Aliquot and store at -20°C. Minimize freezing and thawing.

Forschungsgebiet: Signaltransduktion, Zytoskelett

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

ABIN184722 (0.5µg/ml) staining of human prostate lysate (35µg protein in RIPA buffer). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.

Publikationen

Publikationen: Kato, Satoh, Okabe et al.: "Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis." in: Neoplasia (New York, N.Y.), Vol. 3, Issue 1, pp. 4-9, 2001 (PubMed).